Literature DB >> 20610351

Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions.

Ritu K Soni1, Anna C Porter, James P Lash, Mark L Unruh.   

Abstract

With the increasing prevalence of hypertension, there has been a growing interest in understanding the health-related quality of life (HRQOL) of patients with hypertension. Although hypertension is often perceived as asymptomatic, it is associated with impaired HRQOL because of complications or comorbidities, awareness of the diagnosis, and adverse effects from antihypertensive medications. This article focuses on the literature published since 2000, on HRQOL in elderly hypertensive individuals as well as hypertensives with co-existent diseases, including chronic kidney disease, cardiovascular disease, and diabetes mellitus. Most of the studies found that hypertensive individuals with co-existent co-morbidities tend to have lower HRQOL than those with hypertension alone, and identified the number of co-morbid illnesses as an independent determinant of HRQOL. The most pronounced effect was noted in the physical function domains of HRQOL. Studies have also examined the effects on HRQOL of specific classes of antihypertensive drugs without specific demonstration of superiority of one drug class over another in terms of HRQOL measures. Although there is evidence in favor of angiotensin-converting enzyme-inhibition for improving renal and cardiovascular outcomes in hypertensive patients, its role in ameliorating HRQOL outcomes remains to be established. 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20610351      PMCID: PMC2901238          DOI: 10.1053/j.ackd.2010.04.002

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  77 in total

1.  The first ten years of the World Health Organization.

Authors:  N E LEPPO
Journal:  Minn Med       Date:  1958-08

2.  Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.

Authors:  J Ostman; K Asplund; T Bystedt; B Dahlöf; S Jern; T Kjellström; H Lithell
Journal:  J Intern Med       Date:  1998-08       Impact factor: 8.989

3.  Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group.

Authors: 
Journal:  Diabetes Care       Date:  1999-07       Impact factor: 19.112

Review 4.  Quality of life and diabetes.

Authors:  R R Rubin; M Peyrot
Journal:  Diabetes Metab Res Rev       Date:  1999 May-Jun       Impact factor: 4.876

5.  Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study.

Authors:  Rachel L Perlman; Fredric O Finkelstein; Lei Liu; Erik Roys; Margaret Kiser; George Eisele; Sally Burrows-Hudson; Joseph M Messana; Nathan Levin; Sanjay Rajagopalan; Friedrich K Port; Robert A Wolfe; Rajiv Saran
Journal:  Am J Kidney Dis       Date:  2005-04       Impact factor: 8.860

6.  Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.

Authors:  P Ruggenenti; A Perna; G Gherardi; G Garini; C Zoccali; M Salvadori; F Scolari; F P Schena; G Remuzzi
Journal:  Lancet       Date:  1999-07-31       Impact factor: 79.321

7.  The impact of co-morbid conditions on the SF-36: a primary-care-based study among hypertensives.

Authors:  Omer Aydemir; Cenk Ozdemir; Ertugrul Koroglu
Journal:  Arch Med Res       Date:  2005 Mar-Apr       Impact factor: 2.235

8.  The Hypertension Optimal Treatment study and the importance of lowering blood pressure.

Authors:  L Hansson
Journal:  J Hypertens Suppl       Date:  1999-02

9.  Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study.

Authors:  I Wiklund; K Halling; T Rydén-Bergsten; A Fletcher
Journal:  Blood Press       Date:  1997-11       Impact factor: 2.835

10.  The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: is the whole greater than the sum of its parts?

Authors:  Hwee-Lin Wee; Yin-Bun Cheung; Shu-Chuen Li; Kok-Yong Fong; Julian Thumboo
Journal:  Health Qual Life Outcomes       Date:  2005-01-12       Impact factor: 3.186

View more
  21 in total

1.  Screen time and physical activity behaviours are associated with health-related quality of life in Australian adolescents.

Authors:  Kathleen E Lacy; Steven E Allender; Peter J Kremer; Andrea M de Silva-Sanigorski; Lynne M Millar; Marjory L Moodie; Louise B Mathews; Mary Malakellis; Boyd A Swinburn
Journal:  Qual Life Res       Date:  2011-09-20       Impact factor: 4.147

2.  Development of an Arabic version of the National Eye Institute Visual Function Questionnaire as a tool to study eye diseases patients in Egypt.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Ahmed A Salama; Marina E Israel; Ghada A Elhawary; Ahmed E Radwan; Mohamed M Elgayar; Tamer M El Nakhal; Islam T Elkhateb; Heba A Hashem; Doha K Embaby; Amira A Elabd; Reem K Elwy; Magdi S Yacoub; Hamdy Salem; Mohamed Abdel-Baqy; Ahmad Kassem
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  Quality of Life (QOL) and Its Associated Factors Using WHOQOL-BREF Among Elderly in Urban Puducherry, India.

Authors:  Ganesh Kumar S; Anindo Majumdar; Pavithra G
Journal:  J Clin Diagn Res       Date:  2013-01-12

4.  Effect of elevated blood pressure on quality of life in children with chronic kidney disease.

Authors:  Cynthia Wong; Arlene Gerson; Stephen R Hooper; Matthew Matheson; Marc Lande; Juan Kupferman; Susan Furth; Bradley Warady; Joseph Flynn
Journal:  Pediatr Nephrol       Date:  2016-02-08       Impact factor: 3.714

5.  Quality of life among patients on levothyroxine: A cross-sectional study.

Authors:  Thekraiat Al Quran; Ziad Bataineh; Abdel-Hameed Al-Mistarehi; Abdulhakeem Okour; Othman Beni Yonis; Adi Khassawneh; Rana AbuAwwad; Anood Al Qura'an
Journal:  Ann Med Surg (Lond)       Date:  2020-10-24

Review 6.  Assessing and improving the health-related quality of life of patients with ESRD.

Authors:  Fredric O Finkelstein; Kelli L Arsenault; Ana Taveras; Kwabena Awuah; Susan H Finkelstein
Journal:  Nat Rev Nephrol       Date:  2012-10-23       Impact factor: 28.314

7.  Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention is associated with better health-related quality of life among elderly female cancer survivors.

Authors:  Maki Inoue-Choi; Deann Lazovich; Anna E Prizment; Kim Robien
Journal:  J Clin Oncol       Date:  2013-04-08       Impact factor: 44.544

8.  Effects of long-term psychological intervention on blood pressure and health-related quality of life in patients with hypertension among the Chinese working population.

Authors:  Lei Liu; Min Li; Shaowu Song; Anshi Shi; Si Cheng; Xiawei Dang; Hui Chen; Heng Zhang; A Ziguli; Lifei Cao; Ping Wang; Hui Luan; Yunlong Ma; Songlin Zhang; Zengwu Wang; Xin Wang; Runlin Gao; Gang Tian
Journal:  Hypertens Res       Date:  2017-10-05       Impact factor: 3.872

9.  Quality of life, religious attitude and cancer coping in a sample of Iranian patients with cancer.

Authors:  Mohammad-Kazem Atef-Vahid; Mehdi Nasr-Esfahani; Mohsen Saberi Esfeedvajani; Homayoon Naji-Isfahani; Mohammad Reza Shojaei; Yasavoli M Masoumeh; S Ashrafodin Goushegir
Journal:  J Res Med Sci       Date:  2011-07       Impact factor: 1.852

10.  Relationship between health-related quality of life and blood pressure control in patients with uncontrolled hypertension.

Authors:  Chan Joo Lee; Woo Jung Park; Jung-Won Suh; Eue-Keun Choi; Dong Woon Jeon; Sang-Wook Lim; Dae-Hyeok Kim; Kwang Soo Cha; Bong-Ryeol Lee; Nam-Ho Kim; Tae-Soo Kang; Jong-Won Ha
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.